newsfilter
← Latest News
Business Wire·

Biocept's CNSide Cerebrospinal Fluid Assay Aids in Monitoring Treatment Response and Detects Actionable Biomarkers in Patients with Metastatic Breast Cancer

Case series poster to be presented at the Society for Neuro-Oncology Annual Meeting Biocept, Inc. (NASDAQ:BIOC), a leading provider of molecular diagnostic assays, products and services, today announced the presentation of a multi-institutional case